<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-id journal-id-type="hwp">bioinfo</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4824131</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btv739</article-id>
    <article-id pub-id-type="publisher-id">btv739</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="heading">
          <subject>Genetics and Population Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>HitWalker2: visual analytics for precision medicine and beyond</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Bottomly</surname>
          <given-names>Daniel</given-names>
        </name>
        <xref ref-type="aff" rid="btv739-aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="btv739-aff2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>McWeeney</surname>
          <given-names>Shannon K.</given-names>
        </name>
        <xref ref-type="aff" rid="btv739-aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="btv739-aff2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="btv739-aff3">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wilmot</surname>
          <given-names>Beth</given-names>
        </name>
        <xref ref-type="aff" rid="btv739-aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="btv739-aff2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="btv739-aff3">
          <sup>3</sup>
        </xref>
        <xref ref-type="corresp" rid="btv739-cor1">*</xref>
      </contrib>
      <aff id="btv739-aff1"><sup>1</sup>Knight Cancer Institute, </aff>
      <aff id="btv739-aff2"><sup>2</sup>Oregon Clinical and Translational Research Institute and </aff>
      <aff id="btv739-aff3"><sup>3</sup>Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland OR 97239, USA</aff>
    </contrib-group>
    <author-notes>
      <corresp id="btv739-cor1">*To whom correspondence should be addressed.</corresp>
      <fn id="btv739-FN1">
        <p>Associate Editor: Oliver Stegle</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>15</day>
      <month>4</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>12</month>
      <year>2015</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>12</month>
      <year>2015</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>32</volume>
    <issue>8</issue>
    <fpage>1253</fpage>
    <lpage>1255</lpage>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>8</month>
        <year>2015</year>
      </date>
      <date date-type="rev-recd">
        <day>15</day>
        <month>11</month>
        <year>2015</year>
      </date>
      <date date-type="accepted">
        <day>11</day>
        <month>12</month>
        <year>2015</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author 2015. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2015</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/" license-type="creative-commons">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p><bold>Summary:</bold> The lack of visualization frameworks to guide interpretation and facilitate discovery is a potential bottleneck for precision medicine, systems genetics and other studies. To address this we have developed an interactive, reproducible, web-based prioritization approach that builds on our earlier work. HitWalker2 is highly flexible and can utilize many data types and prioritization methods based upon available data and desired questions, allowing it to be utilized in a diverse range of studies such as cancer, infectious disease and psychiatric disorders.</p>
      <p><bold>Availability and implementation:</bold> Source code is freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/biodev/HitWalker2">https://github.com/biodev/HitWalker2</ext-link> and implemented using Python/Django, Neo4j and Javascript (D3.js and jQuery). We support major open source browsers (e.g. Firefox and Chromium/Chrome).</p>
      <p>
        <bold>Contact:</bold>
        <email>wilmotb@ohsu.edu</email>
      </p>
      <p><bold>Supplementary information:</bold><ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv739/-/DC1">Supplementary data</ext-link> are available at <italic>Bioinformatics</italic> online. Additional information/instructions are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/biodev/HitWalker2/wiki">https://github.com/biodev/HitWalker2/wiki</ext-link></p>
    </abstract>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Across domains, the need to integrate and prioritize genes or variants is a common theme—for therapeutic selection, as well as for mechanistic and perturbation studies. Network-context methods can facilitate the ranking of genes and associated genetic variants/mutations. For instance, some serve to rank the variant genes of individual subjects relative to orthogonal biological assay data (<xref rid="btv739-B3" ref-type="bibr">Bottomly <italic>et al.</italic>, 2013</xref>; <xref rid="btv739-B6" ref-type="bibr">Jia and Zhao, 2014</xref>) whereas others can be used for GWAS or QTL studies (<xref rid="btv739-B7" ref-type="bibr">Köhler <italic>et al.</italic>, 2008</xref>). As a whole, these approaches can integrate different data types and statically report results, but up to now have not focused on making the data ‘accessible’ with respect to discovery, interpretation and knowledge acquisition. To this end we developed HitWalker2, which is a highly customizable approach to both producing a ranked list of genes utilizing network and external information and exploring these results using graph-centric interactive visualizations. Details of the HitWalker2 workflow and framework itself can be found in the <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv739/-/DC1">Supplementary Material</ext-link>.</p>
  </sec>
  <sec>
    <title>2 Description of software</title>
    <sec sec-type="intro">
      <title>2.1 Overview</title>
      <p>The original HitWalker R package provided a means to prioritize variants stored in an SQL database and display the results using a static image of a relevant subnetwork and a text summary that could be exported to an Excel document. Interaction with the program was via R syntax and as such it required a working R environment or access to a server that does and some familiarity with the language (or additional training time).</p>
      <p>HitWalker2 contains all of the features of the original but additionally was designed as an approach to allow users to access meaningful aspects of their data through interactions with genes, subjects and groups as a series of graphs organized as panels. The vast majority of these interactions involve mouse clicks and dragging operations, a paradigm which bench scientists and clinicians will be familiar with.</p>
      <p>HitWalker2 extends the static subnetwork image of HitWalker to allow user interactivity along multiple levels. This interactivity is not just due to relatively basic features such as reorganizing nodes and retrieving information about nodes. More importantly, it provides the ability to ask biologically meaningful questions with or without use of a prioritization approach.</p>
    </sec>
    <sec>
      <title>2.2 Functionality</title>
      <p>In the original Hitwalker framework, the key focus was on prioritizing genes in individual samples. We have extended this in HitWalker2 to now include: (i) summarization and subsetting of cohort-level phenotypic attributes, (ii) cohort-level identification of recurrent genes based on ‘hits’ (as defined by thresholding multiple biological assay results), (iii) identification of subset of cohort with the same hit results in a given set of genes, (iv) pathway-context for results (individual, subset and full cohort), (v) ability to group subjects and genes by specified relationships/queries, (vi) ability to export results via CSV/PDF and (vii) fully interactive web-based visualization platform.</p>
    </sec>
  </sec>
  <sec>
    <title>3 Applications</title>
    <sec sec-type="intro">
      <title>3.1 Overview</title>
      <p>We created a base database for human samples consisting of high confidence STRING interactions (<xref rid="btv739-B5" ref-type="bibr">Jensen <italic>et al.</italic>, 2009</xref>), pathways from Pathway Commons (<xref rid="btv739-B4" ref-type="bibr">Cerami <italic>et al.</italic>, 2011</xref>) and gene symbol mapping information from NCBI (<xref rid="btv739-B8" ref-type="bibr">Maglott <italic>et al.</italic>, 2005</xref>). This database is available at our Github wiki along with steps used in its creation.</p>
      <sec sec-type="cases">
        <title>3.1.1 Precision medicine use case</title>
        <p>One of the major translational challenges is target classification and prioritization in the clinical setting (<xref rid="btv739-B1" ref-type="bibr">Andre <italic>et al.</italic>, 2014</xref>). In this use case, the goal is to rank the cancer variants relative to expression and drug sensitivity that could guide therapeutic selection (<xref ref-type="fig" rid="btv739-F1">Fig. 1</xref>). To illustrate this use case, we utilize cancer expression, variant and drug data from the Cancer Cell Line Encyclopedia (<xref rid="btv739-B2" ref-type="bibr">Barretina <italic>et al.</italic>, 2012</xref>). An expanded demo and walk-through of this example is provided on the Github wiki. We note that Hitwalker2 provides context to allow the user to move beyond individualized prioritization. For the HepG2 example, we have identified a prioritized gene set derived from the corresponding inhibitor assay results. We can then determine whether other samples or members of the cohort have mutations in the same genes (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv739/-/DC1">Supplementary Fig. S1</ext-link>). The interactive panels allow both individual and cohort level summaries. For example, at the cohort level, one can rapidly determine the most recurrently mutated genes in the cohort or for a selected subset of the cohort. Any overexpressed genes or drug sensitivity hits will automatically be displayed as part of the result. Pathways containing interesting genes can then be visualized (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv739/-/DC1">Supplementary Fig. S2</ext-link>). Exporting these results can be done via images of the graph panel(s) as well as text files.
<fig id="btv739-F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>NRAS mutant skin cell lines mutations in the TLR3 Cascade pathway. The set of cell lines with NRAS mutations in the exome data was first retrieved and subsetted to only those cell lines derived from skin. Drug treatment data were used to identify MAPK7 as the most frequently perturbed gene target (GeneScore). The user can then explore the mutational burden of the pathways containing MAPK7, in this example, the Toll-Like Receptor 3 Cascade pathway from Reactome</p></caption><graphic xlink:href="btv739f1p"/></fig>
</p>
      </sec>
      <sec sec-type="cases">
        <title>3.1.2 GWAS evidence-based visualization use case</title>
        <p>ADHD GWAS results (Psychiatric Genetic Consortium; <ext-link ext-link-type="uri" xlink:href="http://www.med.unc.edu/pgc/">http://www.med.unc.edu/pgc/</ext-link>) were combined with study genotypes (unpublished data, JN and BW) and DNA methylation <italic>P</italic>-values (<xref rid="btv739-B9" ref-type="bibr">Wilmot <italic>et al.</italic>, 2015</xref>). In addition to top SNPs identified from a single GWAS study, it is useful to combine GWAS from multiple data sets and additional data types to strengthen the support for biologically important SNPs. For this use case, the focus is on rapidly identifying candidate genes with support across multiple studies and data types (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv739/-/DC1">Supplementary Fig. S3</ext-link>). <italic>P</italic>-values from a case/control meta-analysis of four Attention Deficit Hyperactivity Disorder datasets were used to compare with SNPs from a candidate gene study. This use case could also allow identification of inconsistencies across studies and provide network-context to GWAS results from both a patient and cohort perspective.</p>
      </sec>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>HitWalker2 provides a visual, reproducible and flexible framework for prioritization that is applicable to a large number of clinical, translational and basic science use cases. The interactive framework facilitates discovery and guide interpretation in a robust and scalable way. This is timely given the growing recognition for more emphasis on human–data interactions.</p>
    <p>The HitWalker2 framework is datatype agnostic and can include any type of experiment/assay which at the end suggests an effect on a gene such as variant/mutation data, copy number variation, expression as well as siRNA or drug screens.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="PMC_1" content-type="local-data">
      <caption>
        <title>Supplementary Data</title>
      </caption>
      <media mimetype="text" mime-subtype="html" xlink:href="supp_32_8_1253__index.html"/>
      <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_btv739_HitWalker2_supplemental_r1_v3.pdf"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgement</title>
    <p>We thank Libbey White for helpful discussions and help with figures.</p>
  </ack>
  <sec>
    <title>Funding</title>
    <p>This work was supported in part by grants from the Leukemia and Lymphoma Society, the National Center for Advancing Translational Sciences [5UL1RR024140]; the National Cancer Institute [5P30CA069533-13]; and National Institute for Mental Health [R01-MH099064].</p>
    <p><italic>Conflict of interest:</italic> none declared.</p>
  </sec>
  <ref-list>
    <title>References</title>
    <ref id="btv739-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andre</surname><given-names>F.</given-names></name></person-group><etal/> (<year>2014</year>) <article-title>Prioritizing targets for precision cancer medicine</article-title>. <source>Ann. Oncol</source>., <volume>25</volume>, <fpage>2295</fpage>–<lpage>2303</lpage>.<pub-id pub-id-type="pmid">25344359</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barretina</surname><given-names>J.</given-names></name></person-group><etal/> (<year>2012</year>) <article-title>The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity</article-title>. <source>Nature</source>, <volume>483</volume>, <fpage>603</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">22460905</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottomly</surname><given-names>D.</given-names></name></person-group><etal/> (<year>2013</year>) <article-title>HitWalker: variant prioritization for personalized functional cancer genomics</article-title>. <source>Bioinformatics</source>, <volume>29</volume>, <fpage>509</fpage>–<lpage>510</lpage>.<pub-id pub-id-type="pmid">23303510</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerami</surname><given-names>E.G.</given-names></name></person-group><etal/> (<year>2011</year>) <article-title>Pathway Commons, a web resource for biological pathway data</article-title>. <source>Nucleic Acids Res</source>., <volume>39</volume>, <fpage>D685</fpage>–<lpage>D690</lpage>.<pub-id pub-id-type="pmid">21071392</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>L.J.</given-names></name></person-group><etal/> (<year>2009</year>) <article-title>STRING 8—a global view on proteins and their functional interactions in 630 organisms</article-title>. <source>Nucleic Acids Res</source>., <volume>37</volume>, <fpage>D412</fpage>–<lpage>D416</lpage>.<pub-id pub-id-type="pmid">18940858</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>) <article-title>VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data</article-title>. <source>PLoS Comput. Biol</source>., <volume>10</volume>, <fpage>e1003460</fpage>.<pub-id pub-id-type="pmid">24516372</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>S.</given-names></name></person-group><etal/> (<year>2008</year>) <article-title>Walking the interactome for prioritization of candidate disease genes</article-title>. <source>Am. J. Hum. Genet</source>., <volume>82</volume>, <fpage>949</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">18371930</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglott</surname><given-names>D.</given-names></name></person-group><etal/> (<year>2005</year>) <article-title>Entrez Gene: gene-centered information at NCBI</article-title>. <source>Nucleic Acids Res</source>., <volume>33</volume>, <fpage>D54</fpage>–<lpage>D58</lpage>.<pub-id pub-id-type="pmid">15608257</pub-id></mixed-citation>
    </ref>
    <ref id="btv739-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilmot</surname><given-names>B</given-names></name></person-group><etal/> (<year>2015</year>) <article-title>Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2</article-title>. <source>J. Child Psychol. Psychiatry</source>, <volume>57</volume>, <fpage>152</fpage>–<lpage>160</lpage>.<pub-id pub-id-type="pmid">26304033</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
